Mitomycin Side Effects

Not all side effects for mitomycin may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to mitomycin: intravenous powder for solution

In addition to its needed effects, some unwanted effects may be caused by mitomycin. In the event that any of these side effects do occur, they may require medical attention.

Also, because of the way cancer medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer. Discuss these possible effects with your doctor.

You should check with your doctor immediately if any of these side effects occur when taking mitomycin:

Less common
  • Black, tarry stools
  • blood in urine or stools
  • cough or hoarseness
  • fever or chills
  • lower back or side pain
  • painful or difficult urination
  • pinpoint red spots on skin
  • unusual bleeding or bruising
Rare
  • Redness or pain, especially at place of injection

If any of the following side effects occur while taking mitomycin, check with your doctor or nurse as soon as possible:

Less common
  • Cough
  • decreased urination
  • shortness of breath
  • sores in mouth and on lips
  • swelling of feet or lower legs
Rare
  • Bloody vomit

Some of the side effects that can occur with mitomycin may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common
  • Loss of appetite
  • nausea and vomiting
Less common
  • Numbness or tingling in fingers and toes
  • purple-colored bands on nails
  • skin rash
  • unusual tiredness or weakness

Mitomycin sometimes causes a temporary loss of hair. After treatment has ended, normal hair growth should return.

After you stop taking this drug, it is possible that you may still experience side effects that need medical attention. If you notice any of the following side effects check with your doctor immediately:

  • Blood in urine

Also, check with your doctor if you notice any of the following:

  • Black, tarry stools
  • blood in stools
  • cough or hoarseness
  • decreased urination
  • fever or chills
  • lower back or side pain
  • painful or difficult urination
  • pinpoint red spots on skin
  • red or painful skin
  • shortness of breath
  • swelling of feet or lower legs
  • unusual bleeding or bruising

For Healthcare Professionals

Applies to mitomycin: compounding powder, intravenous powder for injection

Hematologic

Recovery from thrombocytopenia has generally been reported to take place within ten weeks. Approximately 25% of leukopenic or thrombocytopenic episodes have been reported to have not recovered.

Hematologic side effects including bone marrow toxicity (64.4%) have been the most common and most serious toxicity associated with the use of mitomycin. Thrombocytopenia and/or leukopenia have been reported to occur anytime within eight weeks of initiation of therapy. Mitomycin produces cumulative myelosuppression.

Other

Other side effects have included hemolytic uremic syndrome (HUS).

HUS has been reported to occur most often at doses greater than or equal to 60 mg. HUS consists primarily of microangiopathic hemolytic anemia (hematocrit less than or equal to 25%), thrombocytopenia (platelet count less than or equal to 100,000/mm3), and irreversible renal failure (serum creatinine greater than or equal to 1.6 mg/dL). A 52% mortality rate has been associated with this syndrome.

Dermatologic

Dermatologic side effects have included the necrosis and consequent sloughing of tissue which results if the drug is extravasated during injection. Alopecia has been frequently reported. Cellulitis at the injection site has been reported and is occasionally severe. Rashes have rarely been reported. Delayed erythema and/or ulceration has been reported to occur either at or distant from the injection site, weeks to months after mitomycin. Allergic contact dermatitis has also been reported.

Extravasation has been reported even without an accompanying stinging or burning sensation and even if their is adequate blood return when the injection needle is aspirated.

Respiratory

Respiratory side effects have been reported infrequently. However, they may be severe and even life threatening. Adult respiratory distress syndrome has been reported.

Dyspnea with a nonproductive cough and radiographic evidence of pulmonary infiltrates may be indicative of mitomycin-induced pulmonary toxicity.

Adult respiratory distress syndrome has been reported in a few patients receiving mitomycin in combination with other chemotherapy and maintained at fraction of inspired oxygen concentrations greater than 50% perioperatively. Because oxygen itself is toxic to the lungs, it is recommended to use only enough oxygen to provide adequate arterial saturation.

Renal

No correlation between the total dose administered or duration of therapy and the degree of renal impairment has been reported.

Renal side effects including a statistically significant rise in creatinine (2%) have been reported.

Cardiovascular

Cardiovascular side effects including congestive heart failure have rarely been reported. Edema and thrombophlebitis have also been reported.

Almost all of the patients who experience congestive heart failure had received prior doxorubicin therapy.

General

General side effects including fever, headache, confusion, drowsiness, syncope, fatigue, and pain have been reported.

Gastrointestinal

Gastrointestinal side effects including anorexia, nausea, vomiting and diarrhea have been reported.

Genitourinary

Genitourinary side effects including two cases of urethral slough and one case of necrosis of the glans penis have been reported.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web3)